153 related articles for article (PubMed ID: 25880516)
1. Myocardial tissue caveolae.
Sanon VP; Sawaki D; Mjaatvedt CH; Jourdan-Le Saux C
Compr Physiol; 2015 Apr; 5(2):871-86. PubMed ID: 25880516
[TBL] [Abstract][Full Text] [Related]
2. Caveolae, caveolin, and cavins: potential targets for the treatment of cardiac disease.
Das M; Das DK
Ann Med; 2012 Sep; 44(6):530-41. PubMed ID: 21651441
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
4. The Caveolin genes: from cell biology to medicine.
Williams TM; Lisanti MP
Ann Med; 2004; 36(8):584-95. PubMed ID: 15768830
[TBL] [Abstract][Full Text] [Related]
5. Distinction between signaling mechanisms in lipid rafts vs. caveolae.
Sowa G; Pypaert M; Sessa WC
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14072-7. PubMed ID: 11707586
[TBL] [Abstract][Full Text] [Related]
6. Caveolae and caveolins in the cardiovascular system.
Gratton JP; Bernatchez P; Sessa WC
Circ Res; 2004 Jun; 94(11):1408-17. PubMed ID: 15192036
[TBL] [Abstract][Full Text] [Related]
7. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
Hnasko R; Lisanti MP
Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453
[TBL] [Abstract][Full Text] [Related]
8. Effect of ischemia reperfusion injury and epoxyeicosatrienoic acids on caveolin expression in mouse myocardium.
Chaudhary KR; Cho WJ; Yang F; Samokhvalov V; El-Sikhry HE; Daniel EE; Seubert JM
J Cardiovasc Pharmacol; 2013 Mar; 61(3):258-63. PubMed ID: 23403888
[TBL] [Abstract][Full Text] [Related]
9. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression.
Jasmin JF; Mercier I; Hnasko R; Cheung MW; Tanowitz HB; Dupuis J; Lisanti MP
Cardiovasc Res; 2004 Sep; 63(4):747-55. PubMed ID: 15306231
[TBL] [Abstract][Full Text] [Related]
10. cav-p60 expression in rat muscle tissues. Distribution of caveolar proteins.
Voldstedlund M; Vinten J; Tranum-Jensen J
Cell Tissue Res; 2001 Nov; 306(2):265-76. PubMed ID: 11702238
[TBL] [Abstract][Full Text] [Related]
11. The role of caveolin-1 in cardiovascular regulation.
Rahman A; Swärd K
Acta Physiol (Oxf); 2009 Feb; 195(2):231-45. PubMed ID: 18826501
[TBL] [Abstract][Full Text] [Related]
12. Cavin proteins: New players in the caveolae field.
Briand N; Dugail I; Le Lay S
Biochimie; 2011 Jan; 93(1):71-7. PubMed ID: 20363285
[TBL] [Abstract][Full Text] [Related]
13. Genetic ablation of caveolin-1 confers protection against atherosclerosis.
Frank PG; Lee H; Park DS; Tandon NN; Scherer PE; Lisanti MP
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):98-105. PubMed ID: 14563650
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae.
Razani B; Wang XB; Engelman JA; Battista M; Lagaud G; Zhang XL; Kneitz B; Hou H; Christ GJ; Edelmann W; Lisanti MP
Mol Cell Biol; 2002 Apr; 22(7):2329-44. PubMed ID: 11884617
[TBL] [Abstract][Full Text] [Related]
15. The caveolar membrane system in endothelium: From cell signaling to vascular pathology.
Filippini A; Sica G; D'Alessio A
J Cell Biochem; 2018 Jul; 119(7):5060-5071. PubMed ID: 29637636
[TBL] [Abstract][Full Text] [Related]
16. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
[TBL] [Abstract][Full Text] [Related]
17. Caveolins and cavins in the trafficking, maturation, and degradation of caveolae: implications for cell physiology.
Busija AR; Patel HH; Insel PA
Am J Physiol Cell Physiol; 2017 Apr; 312(4):C459-C477. PubMed ID: 28122734
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 null (-/-) mice show dramatic reductions in life span.
Park DS; Cohen AW; Frank PG; Razani B; Lee H; Williams TM; Chandra M; Shirani J; De Souza AP; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
Biochemistry; 2003 Dec; 42(51):15124-31. PubMed ID: 14690422
[TBL] [Abstract][Full Text] [Related]
19. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
Smythe GM; Eby JC; Disatnik MH; Rando TA
J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
[TBL] [Abstract][Full Text] [Related]
20. Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases.
Sotgia F; Bonuccelli G; Minetti C; Woodman SE; Capozza F; Kemp RG; Scherer PE; Lisanti MP
Am J Pathol; 2003 Dec; 163(6):2619-34. PubMed ID: 14633633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
